- Home
- IMMP vs JRS Comparison
IMMP vs JRS Comparison
Compare IMMP & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- JRS
- Stock Information
- Founded
- IMMP 1987
- JRS 2001
- Country
- IMMP Australia
- JRS United States
- Employees
- IMMP N/A
- JRS N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- JRS Finance/Investors Services
- Sector
- IMMP Health Care
- JRS Finance
- Exchange
- IMMP Nasdaq
- JRS Nasdaq
- Market Cap
- IMMP 211.1M
- JRS 231.7M
- IPO Year
- IMMP N/A
- JRS N/A
- Fundamental
- Price
- IMMP $1.78
- JRS $7.90
- Analyst Decision
- IMMP Buy
- JRS
- Analyst Count
- IMMP 1
- JRS 0
- Target Price
- IMMP $7.00
- JRS N/A
- AVG Volume (30 Days)
- IMMP 150.7K
- JRS 86.6K
- Earning Date
- IMMP 02-27-2025
- JRS 01-01-0001
- Dividend Yield
- IMMP N/A
- JRS 8.87%
- EPS Growth
- IMMP N/A
- JRS N/A
- EPS
- IMMP N/A
- JRS N/A
- Revenue
- IMMP $3,019,249.00
- JRS N/A
- Revenue This Year
- IMMP $50.37
- JRS N/A
- Revenue Next Year
- IMMP N/A
- JRS N/A
- P/E Ratio
- IMMP N/A
- JRS N/A
- Revenue Growth
- IMMP 24.11
- JRS N/A
- 52 Week Low
- IMMP $1.32
- JRS $5.95
- 52 Week High
- IMMP $2.86
- JRS $8.00
- Technical
- Relative Strength Index (RSI)
- IMMP 44.44
- JRS 51.52
- Support Level
- IMMP $1.88
- JRS $7.69
- Resistance Level
- IMMP $1.94
- JRS $7.97
- Average True Range (ATR)
- IMMP 0.12
- JRS 0.13
- MACD
- IMMP -0.03
- JRS 0.01
- Stochastic Oscillator
- IMMP 0.00
- JRS 66.67
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests primarily in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.